Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levine, H.
Right arrow Articles by Cobb, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Levine, H.
Right arrow Articles by Cobb, J.

Chest, Vol 73, 202-206, Copyright © 1978 by American College of Chest Physicians

ARTICLES

Therapeutic properties of oral ambruticin (W7783) in experimental pulmonary coccidioidomycosis of mice

HB Levine, SM Ringel and JM Cobb

Oral administration of ambruticin (W7783) (by gavage) was lifesaving in mice infected intranasally with arthrospores of Coccidioides immitis. Doses of 25 and 50 mg/kg of body weight, given twice daily by different schedules for from 17 to 60 days, eradicated the fungus from 71 to 100% of the infected mice. Lower doses (5 or 10 mg/kg once or twice daily by an intermittent 50-day regimen) prevented death in all instances but produced many fewer biologic cures. The animals tolerated all these doses well but were adversely affected by doses of 200 mg/kg given daily. Resistance to the drug was not induced by prolonged treatment. Dose-related fungicidal and fungistatic properties in vitro correlated with doses that were life-sustaining or curative (or both) in vivo.


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
L. F. Shubitz, J. N. Galgiani, Z.-Q. Tian, Z. Zhong, P. Timmermans, and L. Katz
Efficacy of ambruticin analogs in a murine model of coccidioidomycosis.
Antimicrob. Agents Chemother., October 1, 2006; 50(10): 3467 - 3469.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1978 by the American College of Chest Physicians.